Herpes Virus
Showing 1 - 25 of 7,789
Frequency of Symptomatic Herpes Virus I and II in HIV Infected
Recruiting
- HIV Disease
- +2 more
- Blood draw
-
Los Angeles, CaliforniaGlobal Research Institute
Apr 9, 2023
Herpes Virus Infections in Kidney Transplant Patients
Recruiting
- Kidney Transplant; Complications
- +2 more
-
Aarhus, Denmark
- +4 more
Jan 30, 2023
Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)
Recruiting
- Virus
- +3 more
- Purell Hand Sanitizer
- Medical Grade Mineral Oil
-
Pocatello, Idaho
- +2 more
Nov 13, 2023
Herpesviruses Reactivation In Hiv-Infected Women Initiating ART
Completed
- Herpes Virus-Related Illnesses
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2022
Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed
- Neonatal Herpes Simplex Infection
- +7 more
-
Copenhagen, Denmark
- +1 more
Dec 25, 2022
Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)
Recruiting
- Neonatal Herpes Simplex Infection
-
Birmingham, AlabamaUniversity of Alabama - Children's of Alabama
Sep 12, 2022
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Suspended
- HSV-2 Infection
- Herpes Simplex Virus Infection
- Diagnostic Test: NOWDx HSV-2 Test
-
Tempe, Arizona
- +2 more
Sep 29, 2022
Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)
Completed
- Chronic Fatigue Syndrome
-
Stanford, CaliforniaStanford University Medical Center
May 23, 2022
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Herpes Labialis Trial in Germany (drug, behavioral, procedure)
Active, not recruiting
- Herpes Labialis
- HDIT101 (blinded therapy)
- +5 more
-
Berlin, Germany
- +4 more
Jan 26, 2023
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023
Herpes Simplex-virus Type 1 (HSV-1) Reactivation
Recruiting
- Tracheobronchitis
- Herpes Simplex Infection
- Patients with herpes-simplex infection requiring bronchoscopy
-
Münster, GermanyUniversity Hospital Münster
Apr 11, 2022
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Intravenous Acyclovir in Oncologic Paediatric Patients
Active, not recruiting
- Herpesviridae Infections
- +4 more
- Pharmacokinetic analysis
-
Trieste, TS, ItalyIRCCS Burlo Garofolo, Bone Marrow Transplant Unit, Institute for
Jan 19, 2022
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg
Withdrawn
- Herpes Simplex Virus Keratitis
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
-
New York, New YorkNew York University School of Medicine
Dec 29, 2021
Recurrent Genital Herpes Trial (UB-621)
Not yet recruiting
- Recurrent Genital Herpes
- UB-621
- (no location specified)
May 16, 2022